Picture of Precision Biosciences logo

DTIL — Precision Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Precision BioSciences Inc reports results for the quarter ended in June - Earnings Summary

* Precision BioSciences Inc  DTIL.OQ  reported quarterly
adjusted
earnings of $4.67​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-3.00.  The mean expectation of seven analysts
for the quarter was for a loss of $1.50 per share. Wall Street
expected results to range from $-2.87 to -50 cents per share.
    * Revenue rose 152.2% to $49.90 million from a year ago;
analysts
expected $8.86 million. 
    * Precision BioSciences Inc's reported EPS for the quarter
was
$4.67​.
    * The company reported quarterly net income of $32.75
million.
    * Precision BioSciences Inc shares had fallen by 1.6% this
quarter and lost 12.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 17.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Precision
BioSciences Inc is $30.00 
This summary was machine generated from LSEG data August 2 at
07:48 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.50          -0.35          Beat
 Mar. 31 2024      -1.91          -0.35          Beat
 Dec. 31 2023      -2.05          -4.06          Missed
 Sep. 30 2023      -4.87          -2.10          Beat

Recent news on Precision Biosciences

See all news